According to NRC Health 's latest financial reports the company's current revenue (TTM) is $0.14 B. In 2022 the company made a revenue of $0.15 B an increase over the years 2021 revenue that were of $0.14 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.14 B | -2.04% |
2022 | $0.15 B | 2.44% |
2021 | $0.14 B | 11.01% |
2020 | $0.13 B | 4.14% |
2019 | $0.12 B | 6.93% |
2018 | $0.11 B | 1.81% |
2017 | $0.11 B | 7.47% |
2016 | $0.10 B | 6.88% |
2015 | $0.10 B | 3.55% |
2014 | $98.83 M | 6.75% |
2013 | $92.59 M | 7.14% |
2012 | $86.42 M | 14.06% |
2011 | $75.76 M | 19.51% |
2010 | $63.39 M | 9.89% |
2009 | $57.69 M | 13.09% |
2008 | $51.01 M | 4.27% |
2007 | $48.92 M | 11.77% |
2006 | $43.77 M | 34.95% |
2005 | $32.43 M | 9.28% |
2004 | $29.68 M | 10.25% |
2003 | $26.92 M | 20.26% |
2002 | $22.38 M | 26.67% |
2001 | $17.67 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
![]() NRC Health
NRC | $0.14 B | 0.00% | ๐บ๐ธ USA |